在KRAS和NRAS的活性状态中的动态形状平衡
Enrico Rennella1, Chrystèle Henry2, Callum J Dickson3
1University of Toronto, Department of Biochemistry Toronto Canada.
RSC chemical biology
|December 12, 2024
概括
了解KRAS和NRAS的动态是开发有效的癌症药物的关键. 这项研究揭示了突变如何改变RAS蛋白状态,指导了像MRTX1133.3这样的向疗法的设计.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 结构生物学是结构生物学.
背景情况:
- RAS蛋白 (KRAS,NRAS) 在细胞信号传递中起着至关重要的作用.
- 在RAS的致癌突变驱动癌症的发展.
- 定位RAS需要了解其结构动态.
研究的目的:
- 描述GTP状态KRAS和NRAS中的交换机-1的动态.
- 为了研究瘤基因突变对RAS形态平衡的影响.
- 阐明KRAS G12D抑制剂的作用机制.
主要方法:
- 使用了31PNMR,15N放松分散NMR和HDX-MS.
- 进行了分子动力学模拟.
- 研究了KRAS G12D抑制剂MRTX1133.3的结合机制.
主要成果:
- 在KRAS和NRAS中确定了两个构造状态 (无活性状态-1,活性状态-2).
- 克拉斯突变 (G12D,G12C,G12V) 稍微有利于不活跃状态.
- NRAS Q61R突变强烈支持活跃状态;MRTX1133锁定了 KRAS G12D 在不活跃状态.
结论:
- RAS的瘤基因突变对形状动态有不同的影响.
- 了解这些动态对于设计特定的RAS抑制剂至关重要.
- MRTX1133通过稳定不活跃的形状,有效地抑制KRAS G12D.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K


